Revolution Medicines, Inc. — insider transactions

15 transactions on record · CIK 1628171

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
15
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$14.7M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$5.4M
2026-08-21
Director share, 12m
0.0%
of transactions where role is stated
Current run
15 sells
consecutive same-direction transactions
Net 3m flow
-$14.7M
purchases minus sales
Total on record
15

Transactions

15 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-292026-09-254Cislini JeffGeneral CounselOpen market sale765$207.32$158.6Kfiling
2026-09-182026-09-162Anders JackChief Financial OfficerOpen market sale61$195.00$11.9Kfiling
2026-09-182026-09-162Anders JackChief Financial OfficerOpen market sale3,992$199.30$795.6Kfiling
2026-09-182026-09-162Cislini JeffGeneral CounselOpen market sale52$195.01$10.1Kfiling
2026-09-182026-09-162Cislini JeffGeneral CounselOpen market sale3,314$199.30$660.5Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselExercise of derivative26,600$21.61$574.8Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselOpen market sale25,817$209.25$5.4Mfiling
2026-08-252026-08-214Cislini JeffGeneral CounselOpen market sale3,314$212.06$702.8Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselOpen market sale3,400$207.24$704.6Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselOpen market sale2,540$210.26$534.1Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselExercise of derivative29,680$0.00—filing
2026-08-252026-08-214Cislini JeffGeneral CounselExercise of derivative29,680$18.56$550.9Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselOpen market sale17,323$208.37$3.6Mfiling
2026-08-252026-08-214Cislini JeffGeneral CounselOpen market sale4,500$211.34$951Kfiling
2026-08-252026-08-214Cislini JeffGeneral CounselExercise of derivative26,600$0.00—filing

Source: U.S. Securities and Exchange Commission, EDGAR

Revolution Medicines, Inc. insider transactions — 15 filings on record — investment.com